Healthy volunteers help sharpen cancer blood test
NCT ID NCT02302885
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study collected blood from 43 healthy adults aged 18-60 to serve as a control group for a test that detects circulating tumor cells in cancer patients. Volunteers provided about 20 mL of blood at up to 20 different times. The goal is to make the cancer detection test more accurate by comparing results from healthy people to those with cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help make a blood test for detecting cancer cells more reliable, potentially leading to earlier cancer diagnosis.
- What could go wrong
- This is a small, completed study with only 43 healthy volunteers. It does not test a treatment, and the results may not fully represent real-world cancer detection scenarios.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test